Details:

Alternative Title:
J Subst Use Addict Treat
Personal Author:
DeSisto, Carla L. ; Terplan, Mishka ; Kacha-Ochana, Akadia ; Green, Jody L. ; Mueller, Trisha ; ... More +
DeSisto, Carla L. ; Terplan, Mishka ; Kacha-Ochana, Akadia ; Green, Jody L. ; Mueller, Trisha ; Cox, Shanna ; Ko, Jean Y. Less -
Description:
Introduction:

Screening for opioid misuse and treatment for opioid use disorder are critical for reducing morbidity and mortality. We sought to understand the extent of self-reported past 30-day buprenorphine use in various settings among women of reproductive age with self-reported nonmedical prescription opioid use being assessed for substance use problems.

Methods:

The study collected data from individuals being assessed for substance use problems using the Addiction Severity Index–Multimedia Version in 2018–2020. We stratified the sample of 10,196 women ages 12–55 self-reporting past 30-day nonmedical prescription opioid use by buprenorphine use and setting type. We categorized setting types as: buprenorphine in specialty addiction treatment, buprenorphine in office-based opioid treatment, and diverted buprenorphine. We included each woman’s first intake assessment during the study period. The study assessed number of buprenorphine products, reasons for using buprenorphine, and sources of buprenorphine procurement. The study calculated frequency of reasons for using buprenorphine to treat opioid use disorder outside of a doctor-managed treatment, overall and by race/ethnicity.

Results:

Overall, 25.5 % of the sample used buprenorphine in specialty addiction treatment, 6.1 % used buprenorphine prescribed in office-based treatment, 21.7 % used diverted buprenorphine, and 46.7 % reported no buprenorphine use during the past 30 days. Among women who reported using buprenorphine to treat opioid use disorder, but not as part of a doctor-managed treatment, 72.3 % could not find a provider or get into a treatment program, 21.8 % did not want to be part of a program or see a provider, and 6.0 % reported both; a higher proportion of American Indian/Alaska Native women (92.1 %) reported that they could not find a provider or get into a treatment program versus non-Hispanic White (78.0 %), non-Hispanic Black (76.0 %), and Hispanic (75.0 %) women.

Conclusions:

Appropriate screening for nonmedical prescription opioid use to assess need for treatment with medication for opioid use disorder is important for all women of reproductive age. Our data highlight opportunities to improve treatment program accessibility and availability and support the need to increase equitable access for all women.


Subjects:
[+]
Adult Analgesics, Opioid Buprenorphine Female Humans Male Opioid-Related Disorders Prescriptions Reproduction
Keywords:
[+]
Nonmedical Prescription Opioid Use Self-reported Women
Source:
J Subst Use Addict Treat. 155:209083
Pubmed ID:
37245854
Pubmed Central ID:
PMC10676438
Document Type:
Journal Article
Funding:
CC999999/ImCDC/Intramural CDC HHSUnited States/
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:74596cf73645913ae78d90bbf9beb24501d37aa86833085691852c86c3b769a5
File Type:

• Supporting Files:
  No Additional Files

More +